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Abstract 
Background: Apocarotenoids, like the C13‑norisoprenoids, are natural compounds that contribute to the flavor and/
or aroma of flowers and foods. They are produced in aromatic plants—like raspberries and roses—by the enzymatic 
cleavage of carotenes. Due to their pleasant aroma and flavour, apocarotenoids have high commercial value for the 
cosmetic and food industry, but currently their production is mainly assured by chemical synthesis. In the present 
study, a Saccharomyces cerevisiae strain that synthesizes the apocarotenoid β‑ionone was constructed by combining 
integrative vectors and high copy number episomal vectors, in an engineered strain that accumulates FPP.
Results: Integration of an extra copy of the geranylgeranyl diphosphate synthase gene (BTS1), together with the 
carotenogenic genes crtYB and crtI from the ascomycete Xanthophyllomyces dendrorhous, resulted in carotenoid 
producing cells. The additional integration of the carotenoid cleavage dioxygenase gene from the plant Petunia 
hybrida (PhCCD1) let to the production of low amounts of β‑ionone (0.073 ± 0.01 mg/g DCW) and changed the color 
of the strain from orange to yellow. The expression of the crtYB gene from a high copy number plasmid in this former 
strain increased β‑ionone concentration fivefold (0.34 ± 0.06 mg/g DCW). Additionally, the episomal expression of 
crtYB together with the PhCCD1 gene in the same vector resulted in a final 8.5‑fold increase of β‑ionone concentration 
(0.63 ± 0.02 mg/g DCW). Batch fermentations with this strain resulted in a final specific concentration of 1 mg/g DCW 
at 50 h, which represents a 15‑fold increase.
Conclusions: An efficient β‑ionone producing yeast platform was constructed by combining integrative and episo‑
mal constructs. By combined expression of the genes BTS1, the carotenogenic crtYB, crtI genes and the plant PhCCD1 
gene—the highest β‑ionone concentration reported to date by a cell factory was achieved. This microbial cell factory 
represents a starting point for flavor production by a sustainable and efficient process that could replace current 
methods.
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Background
Terpenoids or isoprenoids are the largest and most 
diverse group of natural compounds found in nature 
[1]. Their biochemical role in cells is diverse ranging 
from cell membrane components through functions in 
subcellular targeting and regulation to plant defense, 
communication, and pigmentation [2, 3]. Terpenoids 
have attractive commercial applications as biofuels, 
antiseptics, flavour and fragrances, and medical agents, 
among others, which has recently raised the interest 
for their commercial production [4–6]. In plants and 
yeast, isoprenoids can be produced through the meva-
lonate pathway, which condenses acetyl-CoA to produce 
the universal isoprene building unit (C5), isopentenyl 
diphosphate (IPP) [1]. Successive condensations of IPP, 
and its isomer dimethylallyldiphosphate (DMAPP), 
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result in isoprenoid precursors of different length: gera-
nyl diphosphate (GPP) for monoterpenes (C10), farnesyl 
diphosphate (FPP) for sesquiterpenes (C15), geranylge-
ranyl diphosphate (GGPP) for diterpenes (C20), 2 units 
of FPP for triterpenes (C30) and 2 units of GGPP for 
tetraterpenes (C40) [1, 7].
Apocarotenoids are a subclass of isoprenoids, which 
are highly appreciated in the flavoring industry due to 
their characteristic aromatic notes [8]. In plants, these 
compounds are produced by the cleavage of carotenoids 
(C40) by the enzymatic action of CCDs (carotenoid 
cleavage dioxygenases), a family of oxidative enzymes 
that specifically cleaves double bonds [9]. Between the 
different apocarotenoids, β-ionone is a prominent scent 
and aromatic molecule present in many flowers and 
fruits, such as blackberries, peaches and apricots, among 
others [10]. In odorant terms, ionones (α and β) are asso-
ciated with violet  scent, but β-ionone has also a woody 
odor character. Despite their low concentration in plants 
(in the order of ng/kg fresh weight), these compounds 
have the potential to strongly impact the flower aroma 
due to their significantly low odor threshold (7 ppt in 
water), only comparable to the rose-like aroma molecule, 
β-damascenone [11]. In nature, β-ionone is obtained by 
specific cleavage of β-carotene [10, 12]. This reaction is 
catalyzed by the action of CCD1, which cleaves carote-
noids at the 9,10 position and the 9′,10′ position in the 
presence of oxygen [13]. Currently, β-ionone is used in 
the food and cosmetic industry due to its pleasant aroma 
and its contribution to flavor, but it is also a key interme-
diate in the synthesis of vitamins A, E and K and there-
fore has an annual production of several hundreds of 
tonnes [14].
The extraction of aroma compounds from their natu-
ral source is an expensive and arduous task, strongly 
dependent on agriculture and all the factors surround-
ing it [8]. Biotechnology represents a very attractive 
alternative for the sustainable production of flavors and 
fragrances that can still be considered as “natural” [15]. 
With the increasing development of genetic engineering, 
it became possible to produce heterologous products in 
microbial cell factories that are normally found only in 
small amounts in nature  [16].
Central to any genetic manipulation is the vector used 
to transform DNA into the host. Vectors that can be inte-
grated into the host chromosome are widely used because 
of  their mitotic stability without the need of selection 
pressure. A series of site-specific integrating vectors has 
recently been designed making possible to transfer up 
to 22 genes in Saccharomyces cerevisiae [17]. This plas-
mid collection ensures stable expression, as all genes are 
genomically integrated in sites separated by essential 
genes minimizing the risk of homologous recombination 
between multiply used promoters or terminators. Fur-
thermore, marker recycling can eliminate all markers in 
the host strain. Episomal vectors on the other hand, like 
multiple-copy plasmids, are still broadly used to ensure 
high-level expression of exogenous or endogenous genes 
for protein production and synthetic pathway optimiza-
tion [18]. This type of expression is also useful in evaluat-
ing possible bottleneck enzymes in a pathway or the role 
of a particular protein under certain conditions.
To date, co-expression of the plant CCD1 enzyme 
together with the Xanthophyllomyces dendrorhous carot-
enoid enzymes in Escherichia coli and S. cerevisiae, respec-
tively, has led to the proof-of-principle biotechnological 
production of β-ionone. A β-carotene overproducing E. 
coli strain, together with the episomal expression of the 
CCD1 gene from Petunia hybrida, was used to demon-
strate the activity of the CCD1 enzyme [10]. For β-ionone 
production by S. cerevisiae, a crtYB/crtI/crtE polycistronic 
episomal construct with the three genes necessary for the 
synthesis of β-carotene from FPP was expressed together 
with the CCD1 gene from raspberry (Figure 1). However, 
the low translational efficiency of this system, limited 
β-ionone production to a final titer of 0.22 mg/L [19].
In the present study, an alternative S. cerevisiae plat-
form was constructed to synthesize β-ionone by com-
bining two genetic engineering approaches to increase 
protein expression: USER cloning-compatible integrative 
vectors and high copy number episomal expressions sys-
tems. By overexpressing a truncated version of the HMG1 
gene (tHMG1) and the endogenous GGPP synthase gene 
BTS1, together with the crtYB and the crtI genes from 
Xanthophyllomyces dendrorhous and the CCD1 gene 
from P. hybrida (PhCCD1) in an FPP overproducing 
strain (SCGIS22) [20], we generated a β-ionone produc-
ing microbial cell factory, reaching a maximal concentra-
tion of 0.63 ± 0.02 mg/g biomass in shake flask cultures. 
In 2 L batch bioreactors, a final concentration of 1 mg/g 
biomass was reached, equivalent to a 15-fold increase. 
This corresponds to a titer of more than 5  mg/L, far 
exceeding the earlier study, and representing a starting 
point for flavor production by a sustainable and efficient 
process that could also replace current methods [21, 22].
Results
Integration of the tHMG1 gene and the β‑ionone pathway
The C13-norisoprenoid β-ionone was synthesized in the 
FPP-overproducing S. cerevisiae strain SCIGS22. This 
strain combines several strategies to overproduce isopre-
noid precursors. It overexpresses ERG20 (responsible for 
the production of FPP from IPP and DMAPP) and since 
FPP is the precursor of many essential compounds in 
yeast, the ERG9 gene (whose gene product synthesizes 
squalene from FPP) was downregulated. Additionally, the 
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LPP1 and DPP1 genes were deleted in order to minimize 
farnesol formation—one of the major alternative path-
ways from FPP.
In this strain we integrated the cassette pIRP01 car-
rying a truncated version of the HMG1 gene, called 
tHMG1, which encodes the mevalonate pathway 
enzyme  3-hydroxy-3-methyl-glutaryl-CoA reductase 
(HMGR) lacking the trans-membrane region [23]. This 
new strain was called SCIGS22a (Figure 1).
In the SCIGS22a strain, the integration of the cas-
settes pIJL01 (BTS1 and crtYB genes) and pIJL02 (crtI 
gene) resulted in orange cells (strain JLS01) (Tables 1, 2), 
indicating the synthesis of the colored carotenoids lyco-
pene and β-carotene. On the other hand, the integration 
of pIJL01 together with pIJL03 (crtI and PhCCD1 genes) 
resulted in yellow cells with a faint, pleasant violet flavor 
(strain JL02) (Figure  2). Transformants were grown on 
SC-URA plates without any color loss over time, indicat-
ing the genetic stability of the cells. When these strains 
were grown in a two-phase shake flask culture (with 10% 
dodecane), final biomass measurements were similar to 
the original engineered strain (SCIGS22a), indicating 
that carotenoids and β-ionone production, at least at 
these concentrations, did not affect cell growth (data not 
shown).  
Carotenoid production reached 212  µg/g DCW and 
103 µg/g DCW for strains JLS01 and JLS02, respectively. 
In strain JLS02, almost all carotenoids were in the form 
of β-carotene (77%) and a small percentage in the form 
of lycopene (2%) (Table  3). Additionally, we confirmed 
β-ionone production (0.073 ±  0.01  mg/g DCW) in this 
strain by GC-FID analysis (Table 4). It is worthy to note 
than when β-ionone production was compared after 
growth at different temperatures, at 20 or 30°C, a 30% 
higher content was achieved at lower temperature [24]. 
Transformation with episomal vectors
Accumulation of carotenogenic intermediates (lycopene 
and β-carotene), concomitant with limited production 
of β-ionone when one copy of each gene was integrated, 
Figure 1 Engineering platform for β‑ionone production in yeast. The blue arrows/genes indicate the modifications of the strain SCIGS22 con‑
structed by Scalcinati et al. [20]. The red arrows/genes show the genes expressed in the present study. In SCIGS22, ERG20 (encoding FPP synthase) 
was over‑expressed, DPP1 and LPP1 (encoding lipid phosphate phosphatases) were deleted and the promoter of ERG9 (encoding squalene 
synthase) was replaced with the HXT1 promoter. In the present study, the tHMG1 (encoding a truncated HMG‑CoA reductase), and BTS1 (encoding 
geranylgeranyl diphosphate synthase) genes were overexpressed. The heterologous genes crtYB (encoding phytoene synthase/lycopene cyclase), 
crtI (encoding phytoene desaturase) and PhCCD1 (encoding carotenoid cleavage dioxigenase from P. hybrida) were both integrated and expressed 
episomally. HMG-CoA 3‑hydroxy‑3‑methylglutaryl‑CoA, IPP isopentenyl diphosphate, DMAPP dimethylallyl diphosphate, FPP farnesyl diphosphate, 
GGPP geranylgeranyl diphosphate.
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suggested that there might be a limitation in chan-
neling the different intermediates into the targeted flow 
direction  [25]. To overcome possible bottlenecks in the 
pathway, a series of episomal vectors was constructed 
to generate new transformants, capable of increasing 
β-ionone production.
The transformation of strain JLS02 with episomally 
expressed crtYB, crtI or PhCCD1 genes generated the 
strains JLS03, JLS04 and JLS05, respectively (Table  2). 
Strain JLS03 (with episomal crtYB) resulted in yellow 
cells with a strong violet aroma. This strain reached 
optical densities similar to those reached by the strain 
JLS02 after 48  h of cultivation (3.3 OD600 vs 3.2 OD600, 
respectively) (Table  4), suggesting that the introduc-
tion of this episomal vector did not affect cell growth 
nor resulted in any metabolic burden by vector replica-
tion. After 48 h of fermentation, most of the carotenoids 
were in the form of β-carotene (83.7% of total carote-
noids) (Table 3) and the β-ionone specific concentration 
reached 0.34  ±  0.06  mg/g DCW (Table  4), almost five 
times higher than for strain JLS02 (Figure 3).
Transformation with the crtI (JLS04) or PhCCD1 
(JLS05) carrying plasmids resulted in strains with lighter 
color and with a lower final biomass (Figure 2; Table 4). 
Carotenoid and β-ionone quantification was not always 
possible, given the low biomass concentration reached 
after 48 h of incubation; these strains were therefore not 
considered in further analyses.
Two co-expression vectors with the genes crtYB and 
crtI (pEJL07) and crtYB and PhCCD1 (pEJL08) under 
control of identical promoters and terminators were 
then constructed. The transformation with these vectors 
resulted in strains JLS06 and JLS07, respectively.
Both strains achieved higher β-carotene concentra-
tions than JLS02. Nevertheless, no significant differences 
were observed when compared with JLS03. A different 
result was observed for β-ionone. Both JLS06 and JLS07 
achieved higher β-ionone production when compared 
Table 1 List of S. cerevisiae strains used in this study
Strain Genotype Plasmid References
SCIGS22 MATa MAL2‑8c SUC2 ura3‑52 lpp1Δ :: loxP dpp1Δ :: loxP PERG9Δ  
:: loxP‑PHXT1 gdh1Δ :: loxP PTEF1‑ERG20 PPGK1‑GDH2
None [20]
SCIGS22a SCIG22 + PTEF1‑tHMG1 None This study
JLS01 SCIG22a + PTEF1‑BTS1 PPGK1‑crtYB PTEF1‑crtI None This study
JLS02 SCIG22a + PTEF1‑BTS1 PPGK1‑crtYB PTEF1‑crtI PPGK1‑PhCCD1 None This study
JLS03 JLS02 P426 PGPDcrtYB This study
JLS04 JLS02 P426 PGPDcrtI This study
JLS05 JLS02 P426 PGPDPhCCD1 This study
JLS06 JLS02 P426 PGPDcrtYB PGPDcrtI This study
JLS07 JLS02 P426 PGPDcrtYB PGPDPhCCD1 This study
Table 2 Plasmid used in this study
Plasmid name Plasmid description Reference
pSP‑GM2 URA3‑based expression plasmid carrying a bidirectional PTEF1–PPGK1 promoter
pXI‑5 KlURA3‑based integration plasmid carrying regions for homologous recombination
pXI‑3 KlURA3‑based integration plasmid carrying regions for homologous recombination
pX‑2 KlURA3‑based integration plasmid carrying regions for homologous recombination
P426 GPD URA3‑based expression plasmid carrying a PGPD promoter
pIRP01 PTEF1‑tHMG1 This study
pIJL01 PTEF1‑BTS1‑PPGK1‑crtYB This study
pIJL02 PTEF1‑crtI This study
pIJL03 PTEF1‑crtI‑PPGK1‑CCD1 This study
pEJL04 PGPD‑crtYB This study
pEJL05 PGPD‑crtI This study
pEJL06 PGPD‑PhCCD1 This study
pEJL07 PGPD‑crtYB‑PGPD‑crtI This study
pEJL08 PGPD‑crtYB‑PGPD‑PhCCD1 This study
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to JLS02 (6.8- and 8.5-fold, respectively). Additionally, 
no significant differences in biomass concentration were 
found between strains JLS-02, -03, -06 and -07 (Figure 3; 
Table 4). Finally, production kinetics of JLS02 and JLS07 
strains up to 72  h indicated that the maximal β-ionone 
concentration was reached after 48  h of cultivation in 
shake flask (Figure 4).
qPCR analysis was carried out to correlate gene expres-
sion levels of the introduced genes with carotenoid and 
β-ionone measurements (Figure 5). JLS03 showed a much 
higher expression of the crtYB gene than strain JLS02, 
with an increment of almost 18-fold. For JLS04 and 
JLS05, increased expression of crtI and PhCCD1 genes 
were detected, but for PhCCD1 the increment in expres-
sion was lower compared to crtYB and crtI expression 
in strains JLS03 and JLS04, respectively (only a 3-fold 
increase compared to 18-fold for crtYb and 7-fold for 
crtI). Finally, for the high copy number vectors with dou-
ble genes, both strains JLS06 and JLS07 resulted in clearly 
increased expression of crtYB, surprisingly almost no 
expression increase of crtI (JLS06) and a slight increase in 
expression of PhCCD1 (JLS07) (Figure 5).
β‑Ionone production in 2 L bioreactor
Figure 6 shows that growth dynamics of  strain JLS07 in 
batch mode in a 2 L aerated bioreactor consisted of an 
initial glucose-consuming growth, followed by ethanol 
consumption. Ethanol was produced due to the Crabtree 
effect in S. cerevisiae, and later consumed. For the glu-
cose-consuming phase, the specific growth rate reached 
a μmax = 0.106/h; and for the ethanol consuming phase, 
μmax = 0.05/h.
At stationary phase (after 51  h of cultivation) an 
OD600 =  10.6 was reached; neither glucose nor ethanol 
were found in the culture. 609.6 µg/g of carotenoids were 
determined intracellularly. The  extracellular β-ionone 
concentration reached 5 mg/L.
Discussion
A β-ionone producing yeast platform was constructed 
by expressing the tHMG1 and BTS1 genes, the caroteno-
genic genes crtYB and crtI, and the gene PhCCD1 encod-
ing a β-carotene cleavage enzyme in the engineered S. 
cerevisiae SCIGS22 strain. A maximal β-ionone concen-
tration of 0.63 mg/g was reached with the strain JLS07 in 
shake flask cultures and 1 mg/g DCW in batch bioreac-
tors. This corresponds to an 8.5- and 15-fold increase, 
respectively, compared with our first engineered S. cer-
evisiae JLS02 strain. Additionally, qPCR analysis indi-
cated a significant increase in the expression of crtYB 
and PhCCD1 genes in this strain (18-fold and 4-fold 
increase compared to JLS02, respectively), consistent 
with the highest β-ionone production. The two-phase 
culture employed here allowed the continuous removal 
of β-ionone, a toxic compound that inhibits cell growth 
in S. cerevisiae even at 2 ppm (data not shown).
Influence of the expression system on β‑ionone production
The large number of genes required for the heterolo-
gous synthesis of β-ionone complicates a gene expres-
sion strategy exclusively based on plasmids, given the 
number of genetic markers needed for selection or the 
large plasmid size if expressed from a single vector. For 
Figure 2 Color of the different strains constructed. a Color change 
from strain JLS01, which only expressed the BST1 gene from S. cerevi-
siae and the carotenogenic genes crtYB and crtI from X. dendrorhous, 
to JLS02 that additionally expressed the P. hybrida gene PhCCD1. b 
Color of the different strains expressing episomal versions of the 
crtYb/crtI/PhCCD1 genes. All the strains expressed the integrated BTS1, 
crtYB, crtI and PhCCD1 genes and were subsequently transformed 
with episomal vectors containing crtYB (JLS3), crtI (JLS04), PhCCD1 
(JLS05), crtYB‑crtI (JLS06) and crtYB‑PhCCD1 (JLS07). All pellets were 
obtained after 48 h of cultivation in a two‑phase culture with 10% 
dodecane at 20°C. c Representative plate of the constructed strains. 
Cells were plated after 48 h of cultivation in two‑phase culture with 
10% dodecane.
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the integration of the target genes, two vectors from a 
USER cloning compatible plasmid collection were used. 
The advantage of using this collection is that the recom-
bination sites are strategically positioned in the S. cer-
evisiae genome (between essential genes), making the 
engineered strain stable over time, with minimal risks of 
gene loss by recombination [17]. In our study, no white 
colonies were observed when we integrated these genes, 
strongly indicating the high efficiency of this technique. 
Furthermore, the color was stable over generations, 
suggesting that the recombinant strains are genetically 
stable.
Nevertheless, engineering a metabolic pathway by 
expressing heterologous enzymes normally suffers from 
flux imbalance, as they typically lack the regulatory 
mechanisms present in the native metabolism [23]. For 
determining—and alleviating—possible bottlenecks of 
the pathway, we additionally  expressed selected path-
way genes from derivatives of the native multi-copy 2 
μm plasmid  in the original JLS02 recombinant strain, 
reaching significantly higher β-ionone concentrations 
compared to only integrative expression systems. Addi-
tionally, we observed coloration of the colonies when 
crtYB (alone or with PhCCD1) was expressed from 
an episomal vector (JLS03 or JLS07 vs. JLS02). We 
confirmed an increase in total carotenoids—mostly 
β-carotene—by HPLC analysis.
We can further improve our platform, at least in terms 
of expression, by integrating a higher number of copies 
of the target genes. Verwaal et al. [26] reported a fivefold 
increase in carotenoids in S. cerevisiae using the inte-
grative expression of the crtYB, crtI and BTS1 genes as 
compared to episomal expression. A similar result was 
Table 3 Carotenoid biosynthesis by different strains after 48 h cultivation
Values represent the mean of three independent cultures after 48 h of cultivation.
– not detected.
Carotenoids Carotenoid concentration (µg/g DCW) (% distribution)
JLS02 JLS03 JLS04 JLS05 JLS06 JLS07
Lycopene 1.6 (2) – – – – –
β‑carotene 62.53 (77.2) 181.7 (83.4) 7.37 13.7 140 (86.1) 164.7 (86.1)
Torulene 7.77 (9.6) 19.6 (9) – – 8.78 (5.4) 9 (4.7)
Other carotenes 8.91 (11) 16.55 (7.6) – – 12.05 (7.4) 17.36 (9.1)
Total 81 ± 8.97 217.9 ± 4.42 7.37 ± 12.73 13.7 ± 13.86 162.6 ± 24.03 191.30 ± 44.25
Table 4 β-Ionone production by different strains after 48 h 
cultivation
Values represent the mean ± SD of five independent cultures after 48 h of cul-
tivation.
a Increase fold with respect to strain JLS02.
strain OD at 600 nm β‑ionone 
(ppm)
β‑ionone 
(mg/g DCW)
Increase  
folda
JLS02 3.33 ± 0.14 0.14 ± 0.02 0.073 ± 0.01 –
JLS03 3.22 ± 0.14 0.63 ± 0.13 0.34 ± 0.06 4.7
JLS04 1.43 ± 0.07 0.0 0.0 –
JLS05 1.36 ± 0.08 0.03 ± 0.03 0.04 ± 0.04 –
JLS06 2.76 ± 0.13 0.74 ± 0.06 0.49 ± 0.04 6.84
JLS07 3.06 ± 0.3 0.96 ± 0.08 0.62 ± 0.05 8.5
Figure 3 Total carotenoids and β‑ionone content of the different β‑ionone producing strains. Three replicates of the each strain were cultivated in 
SC‑URA medium with 2% glucose and 10% of dodecane for 48 h. Samples were processed for β‑ionone measurements by GC‑FID and total carot‑
enoids by HPLC. *p < 0.05, **p < 0.01 t test, one‑tailed comparison between measurements.
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obtained in E. coli where the production of β-carotene 
was higher using low-copy plasmids as compared to 
high-copy plasmids [27]. The major problem with the use 
of high copy number vectors is associated with the result-
ing high metabolic burden. To avoid unnecessary enzyme 
synthesis, the identification of bottlenecks and enzyme 
efficiency is a key aspect to express genes accordingly. 
Considering that the plasmid collection used has 11 inte-
grative vectors, with a total capacity to integrate 22 genes 
in different yeast chromosomes, similar expression levels 
to those reached by episomal vectors could in principle 
be obtained, with the additional benefits of stability, and 
no necessity for selection pressure. Nonetheless, consid-
ering that the S. cerevisiae SCIGS22 strain has only uracil 
auxotrophy, each transformation required the removal of 
the previously used URA3 marker gene. Given that the 
5-FOA elimination method is laborious and time con-
suming, successive integration—and marker recycling—
resulted in an arduous and cumbersome transformation 
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and the plant PhCCD1 gene in the different β‑ionone producing 
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process. The development of a new microbial cell factory 
containing several auxotrophies as selection markers 
will allow constructing strains overproducing terpenoids 
easier and faster. Alternatively, the application of tar-
geted genome editing using engineering nucleases, like 
the clustered, regularly interspaced, short palindromic 
repeats (CRISPR) technology, can be used to insert a 
desired sequence through recombination of exogenous 
DNA with a specific locus, without marker selection [28].
Influence of gene expression levels
Four terpenoid pathway genes were expressed in S. cer-
evisiae in order to achieve β-ionone biosynthesis. We 
first expressed an extra copy of the endogenous BTS1 
gene under the strong promoter TEF1. The BTS1 gene is 
normally expressed at low levels in wild type cells [26], 
because the PBTS1 promoter is one of the weakest con-
stitutive promoters related to terpenoid biosynthesis 
[29]. Then, we expressed the crtYB and crtI genes from 
the ascomycete X. dendrorhous to produce β-carotene. 
Both genes encode bifunctional enzymes, commonly 
employed for β-carotene and astaxanthin production in 
microorganisms [30]. Finally, the CCD1 (PhCCD1) gene 
from P. hybrida was expressed to cleave β-carotene to 
β-ionone, since the respective enzyme successfully pro-
duced β-ionone in E. coli [10]. In terms of the genes used 
here, there is also space for further improvement of the 
present strain.
One extra copy of the BTS1 gene may not be sufficient 
to consume the high FPP levels produced by the SGCI22a 
strain. Also, in other studies related with β-carotene pro-
duction in yeast, a GGPP synthase from X. dendrorhous 
(crtE) was expressed, reaching higher concentrations of 
β-carotene [29, 30]. Therefore, further BTS1 over-expres-
sion could lead to a higher accumulation of carotenoids 
and β-ionone; alternatively, crtE over-expression in this 
platform could reach a similar effect.
The accumulation of β-carotene—with minimal 
amounts of lycopene—in our strains suggested a high 
expression and/or a high activity of the CrtI enzyme (also 
by the accumulation of torulene, another carotenoid pro-
duced by the CrtI enzyme). Verwaal et al. [26], expressed 
an extra copy of crtI in a S. cerevisiae strain that carried 
integrated crtYB, crtI and crtE genes, and observed a 
tenfold increase in β-carotene. However, in the present 
study the overexpression of crtI from an episomal vec-
tor (measured by qPCR) resulted in cell growth decrease, 
which make  it difficult to draw an accurate conclu-
sions about the influence of  this gene overexpression on 
β-ionone production. The use of a high copy number vec-
tor to express this gene may cause an overconsumption 
of the available FPP, limiting the synthesis of other essen-
tial compounds like ergosterol (considering that also 
ERG9 was down regulated in this strain). In the case of 
strain JLS06, since there was no increased expression of 
this gene, we conclude no effect of this gene at that time. 
To further evaluate the role of the crtI expression level for 
β-ionone production, an extra copy of the gene could be 
integrated or it would be advised to work with low copy 
number vectors.
Finally, the significant accumulation of β-carotene in all 
constructed strains—JLS03 to JLS07—suggests that the 
PhCCD1 gene might be suboptimally expressed or that 
the enzyme has low catalytic efficiency. The low growth 
of the JLS05 strain may indicate the accumulation of 
inhibitory compounds or the use of other substrates, e.g. 
lipids, even though the PhCCD1 expression was not dra-
matically increased, as compared with the JLS02 strain 
(Figure  5). In carotenoid accumulating microorganisms, 
the maize CCD1 enzyme does not exclusively cleave the 
9,10 and 9′,10′ double bonds of carotenoids, but also the 
5,6 and 5′,6′ bonds [31], indicating that CCD1 might not 
exclusively produce β-ionone. Given that the PhCCD1 
over-expressing strain showed low growth—and neither 
carotene nor volatiles were detected—it was not possible 
to identify the accumulation of toxic or other intermedi-
ate compounds. Nevertheless, strain JLS07 (PhCCD1-
crtYB) reached optical densities similar to strain JLS02, 
indicating that the overexpression of PhCCD1 together 
with crtYB did not produce the same effect in the cells. 
Expression of CCD1 from different organisms or the 
use of other enzymes—like  CCD4 that can  also pro-
duce β-ionone from β-carotene—may further increase 
β-ionone production in yeast. Other possible  strategies 
include the construction of fusion proteins—to reduce 
the access of enzymes to other substrates—or the use of 
an inducible promoter, in order to favoring cell growth 
and β-carotene accumulation at beginning of the fermen-
tation before inducing β-ionone production.
β‑Ionone titer
Beekwilder et  al. [19] recently reported the production 
of β-ionone in S. cerevisiae by heterologous expression 
of a polycistronic construct, an alternative way to syn-
chronously express a heterologous multigene pathway in 
S. cerevisiae. The maximum concentration reached with 
this strategy was 0.22 mg/L. The S. cerevisiae JLS07 strain 
developed here increased the β-ionone production sev-
enfold, achieving a maximal titer of 1.5 mg/L after 72 h 
of cultivation in flask cultures, and a 23-fold increase 
if we consider the 5  mg/L achieved after 50  h in 1.5  L 
bioreactors.
Even though the constructed strains overproduce the 
precursor for the β-ionone pathway, low optical densities 
were reached, probably due to the high-level expression 
of several genes. However, the product yield (Ysp) reached 
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for strain JLS07 in flask cultures was five times higher 
than the Ysp obtained by the polycistronic system.
Batch fermentation in bioreactors differed from flask 
cultures. The OD600 reached a threefold increase and 
the β-ionone concentration was eightfold higher after 
50 h of cultivation compare to flask cultures. The higher 
β-ionone production during the stationary phase can 
result from the accumulation of this compound in the 
dodecane layer. Moreover, the lower expression of the 
PhCCD1 gene, compared to the expression of crtYB 
in this strain, could be related with a slow cleavage of 
β-carotene (compared to its synthesis) since at 100 h of 
fermentation β-ionone continue accumulating, reaching 
a concentration of 8  mg/L and 200  µg/g of carotenoids 
(data not shown). Besides, glucose depletion during this 
stage can repress the ERG9 gene expression under the 
HXT1 promoter, favoring the accumulation of FPP and 
the carotenogenic pathway towards β-ionone synthesis. 
qPCR analysis of the expression of ERG9 and caroteno-
genic genes, together with metabolomics during the fer-
mentation, might help to elucidate this hypothesis.
Conclusions
In this work, we constructed a yeast platform for 
β-ionone production by differential expression of the 
carotenogenic genes crtYB and crtI, and the plant gene 
PhCCD1. The fine-tuning of multi-gene expression, as 
demonstrated in this study for β-ionone biosynthesis, can 
expand our yeast platform towards the synthesis of other 
isoprenoid-derived compounds.
Methods
Plasmid construction
The genes coding for CrtYB, CrtI and PhCCD1 proteins 
were synthesized by Genscript (Piscataway, NJ, USA) 
(Additional file 1). All the sequences were codon opti-
mized for expression in S. cerevisiae. The catalytic domain 
of the HMG-CoA reductase gene (tHMG1) together with 
the TEF1 promoter was PCR amplified using genomic 
DNA from strain SCIGS23 [20] as template and the BTS1 
gene was PCR amplified from genomic DNA of strain 
CEN.PK113-5D. Primers used for all amplifications are 
provided in Additional file 2.
We constructed four plasmids to integrate the tHMG1 
gene and the four genes needed for β-ionone produc-
tion, into the yeast genome, using the USER cloning 
technique [32]. PCR amplification of the DNA fragments 
was carried out in 35 PCR cycles using the proofreading 
PfuTurbo Cx Hotstart polymerase (Agilent Technolo-
gies, Santa Clara, CA, USA) or PfuX7 [33], following the 
manufacturer’s instructions. The USER vector pXI-5 was 
amplified by PCR using primer pair 1/2, and the USER 
vectors pXI-3 and pX-2 were amplified by PCR using 
primer pair 3/4 followed by digestion with the Nb.BsmI 
nicking endonuclease for 1  h. The catalytic domain of 
the HMG-CoA reductase gene (tHMG1) [GenBank 
NM_001182434] together with the TEF1 promoter was 
amplified using primer pair 5/6. The BTS1 gene [Gen-
Bank NM_001183883] was amplified using primer pair 
7/8. The genes crtYB [protein ID AAO53257], crtI [pro-
tein ID AAO47570] and PhCCD1 [protein ID AAT68189] 
were amplified using primers pair 9/10, 11/12 and 13/14, 
respectively. The bidirectional promoters (TEF1/PGK1) 
used for the expression of the genes were amplified from 
the plasmid pSP-GM2 as a template using the prim-
ers 15 and 16. All PCR products were treated with DpnI 
enzyme to eliminate original vector residues. Purified 
digested vector (100  ng) was mixed at a molar ratio of 
(1:1) with purified PCR products amplified depending on 
their length. The DNA fragments were mixed with 1 μL 
of 10 × TE buffer (100 mM Tris–HCl, 1 mM EDTA; pH 
8.0), 1 U of USER enzyme mix (New England BioLabs) 
and Milli-Q purified water until 10 μL. The mixture was 
incubated for 20 min at 37°C, followed by 20 min at 25°C. 
Finally, the reaction mix was used to transform chemi-
cally competent E. coli cells. The resulting plasmids were 
designated pIRP01 (with tHMG1 under the TEF1 pro-
moter), pJL01 (with BTS1 under the TEF1 promoter and 
crtYB under the PGK1 promoter), pJL02 (with crtI under 
the TEF1 promoter) and pJL03 (with crtI under the TEF1 
promoter and PhCCD1 under the PGK1 promoter) Since 
the strain used is auxotroph for uracil (ura3-52), all vec-
tors contained the Kluyveromyces lactis (Kl) URA3 gene 
flanked by direct repeats (in order to be able to recycle 
this marker for future transformations).
We also constructed a series of plasmids for episomal 
expression using the Gibson assembly technique.
All PCRs to obtain DNA fragments suitable for Gib-
son assembly were carried out in 35 PCR cycles using 
Phusion High-Fidelity DNA polymerase (Thermo Sci-
entific, Waltham, MA, USA) following the manufac-
turer’s instructions. Gibson assembly was performed 
as previously described [34] with pairs of primers for 
each fragment to be assembled containing segments of 
about ~40 bp homologous to the adjacent fragment to be 
linked. The episomal yeast expression vector p426GPD 
(Addgene, Cambridge, MA, USA) was amplified with 
the primer pairs 17/18, 19/20 or 21/22 depending on the 
gene cloned. CrtYB, crtI and PhCCD1 were amplified 
using primers 23/24, 25/26 and 27/28, respectively. All 
PCR products were treated with DpnI enzyme to elimi-
nate original vector residues and purified by gel extrac-
tion using the Qiaquick Gel Extraction kit from Qiagen 
according to  the manufacturer’s instructions. The puri-
fied genes fragments and vectors were mixed based on 
their molar ratios in a final volume of 5  µL containing 
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100 ng of total DNA. This DNA mix was added to 15 µL 
of 1.33X master mix (5X isothermal mix buffer, T5 exo-
nuclease 1U/µL, Phusion DNA polymerase 2U/µL, Taq 
DNA ligase 40 U/µL and Milli-Q purified water) and the 
reaction mixture was incubated at 50°C for 1  h. Finally, 
10  μL reaction mix were used directly to transform 
chemically competent E. coli cells. The resulting plasmids 
were designated pEJL04, pEJL05 and pEJL06, containing 
crtYB, crtI and PhCCD1 genes, respectively.
For the construction of two gene-containing plas-
mids—pEJL07 and pEJL08—the pEJL04 plasmid was 
used as backbone and amplified using primers 29/30, 
including crtYb gene. The crtI and PhCCD1 genes were 
amplified from pEJL05 and pEJL06, respectively, includ-
ing in each case the GPD promoter and CYC1 terminator 
using primer 31/32. Maps of all the plasmids constructed 
are in Additional file 3.
All plasmids were verified by sequencing (Macrogen 
Inc., Seoul, Korea).
Yeast strain construction
The S. cerevisiae strain  SCIGS22 used in this work has 
a CEN.PK background with extra modifications in the 
genome for the overproduction of FPP [20].
All S. cerevisiae strains constructed from this strain are 
listed in Table 1.
Strain SCIGS22a carrying the truncated version of the 
HMG1 gene (tHMG1) encoding 3-hydroxy-3-methyl-
glutaryl-CoA reductase lacking the trans-membrane 
region, was created from strain SCIGS22 by transforma-
tion with the cassette from plasmid pIRP01. The plasmid 
was digested with enzyme NotI (New England BioLabs, 
Ipswich, MA, USA), and the fragment purified and trans-
formed into strain SCIGS22, finally called SCIGS22a. 
The transformation was performed using the standard 
lithium acetate/single-stranded DNA carrier/PEG proce-
dure [35] and transformants were selected using SC-URA 
plates. Correct cassette integration into the pXI-5 locus 
was tested by PCR using primers 33/34. The transfor-
mants were grown in YPD medium at 30°C for 48 h and 
then directly spread onto 5-fluoroorotic acid (5-FOA) 
plates (50 mg/L) for the recycling of the KlURA3 marker. 
Colonies grown on 5-FOA plates were examined by col-
ony-PCR using primers 34/35.
JLS01 carrying the genes BTS1, crtYB and crtI was cre-
ated from strain SCIGS22a by transforming the strain 
with the cassettes from plasmids pIJL01 and pIJL02. 
For this purpose, the plasmids pIJL01 and pIJL02 were 
restricted with enzyme SwaI (New England BioLabs) and 
the fragments isolated from vector backbones were used 
for yeast transformation, one cassette at a time. Cor-
rect cassette integration into the pXI-3 locus was tested 
by PCR using primers 36/37. After the KlURA3 marker 
recycling, the cassette from plasmid pIJL02 was used for 
yeast transformation and again the KlURA3 marker was 
recycled for future transformation with episomal plas-
mids. The correct integration of the cassette in the pX-2 
locus was tested by PCR using primers 38/39. Strain 
JLS02 carrying the genes BTS1, crtYB, crtI and CCD1 
was created in the same way, using plasmids pIJL01 and 
pIJL03.
Strains JLS03, JLS04, JLS05, JLS06 and JLS07 were 
obtained transforming the strain JLS02 with the high 
copy number plasmid pEJL04, pEJL05, pEJL06, pEJL07 
and pEJL08, respectively (Table 2) containing the URA3 
gene from S. cerevisiae as selection marker and the genes 
crtYB,  crtI and/or PhCCD1 under control of the strong 
constitutive promoter GPD (Table 1). For all comparative 
analyses, strains JLS01 and JLS02 were transformed with 
an empty vector p426GPD.
Strain maintenance
For long term storage of the strain, a yeast suspensions 
containing 25% (v/v) sterile glycerol was stored in cryovi-
als at −80°C. Working stocks were maintained on YPD 
agar plates containing 10  g/L yeast extract, 20  g/L pep-
tone, 20  g/L glucose and 20  g/L agar. Plasmid carrying 
strains were maintained on synthetic dextrose medium 
(SC) agar plates lacking uracil containing 6.9  g/L yeast 
nitrogen base without amino acids (BD Difco™, BD and 
Co, Sparks, MD, USA), 0.77  g/L complete supplement 
mixture without uracil (CSM-URA) (Sunrise Science 
Products Inc., San Diego, CA, USA), 20 g/L glucose and 
20 g/L agar (BD Difco™ BD and Co.).
Growth conditions
Single colonies were inoculated in 3  mL pre-cultures in 
SCD media without uracil. Then, cultures were grown in 
250 mL shake flasks at 20°C and 180 rpm in a horizontal 
shaking incubator, with a culture volume of 50 mL with 
a second phase of dodecane (10%, v/v). All shake-flask 
cultures were inoculated from pre-cultures grown on the 
same medium, to an initial OD600 of 0.1.
β Ionone quantification
Culture samples were centrifuged for 2 min at 6,000 rpm. 
The organic phase was dried over anhydrous sodium 
sulfate. Quantitation was performed by means of a gas 
chromatography system HP 5890 coupled to a flame 
ionization detector using a DB-FFAP capillary column 
(60 m × 0.25 mm id, 0.25 µm film thickness) (J&W Sci-
entific, Agilent Technologies). Injection of the samples 
was performed in splitless mode at 250°C. The oven 
program started at 80°C for 1  min, then the tempera-
ture was raised up 10°C/min to 120°C and then 3°C/min 
until 240°C. Concentrations of β-ionone were calculated 
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by using a calibration curve in the range of 0.1–50 mg/L 
using 4-isopropyl-3-methylphenol 4IP3MP as internal 
standard (Sigma-Aldrich, St. Luis, MO, USA). Addition-
ally, mass spectra were obtained using a HP5890A gas 
chromatograph connected to a HP 5975 C mass spec-
trometer in electron impact (EI) mode at 70 eV.
Carotenoid analysis
Carotenoid extraction was carried out from cellular pel-
lets according to the acetone extraction method [36], 
with some modifications, using 50  mL culture volume. 
The cell pellet was washed once with deonized water 
and then the cells were broken with 500  µL of 0.5-mm 
glass beads with 1 mL of acetone for 1 min in a cooling 
Bead Beater (Bio Spec Products, Bartlesville, OK, USA). 
After breakage, the bead-cell mixture was centrifuged at 
14,000 rpm for 5 min, and the clear acetone supernatant 
was poured off the cell pellet. This extraction procedure 
was repeated until the cell pellet was white. The acetone 
extracts were combined with 1/5 volume of petroleum 
ether and stirring to separate the two phases to finally 
centrifuge at 14,000 rpm for 5 min. The petroleum ether 
extract was collected and used for the total carotenoid 
quantification.
The total carotenoid composition was calculated 
by using the 1% extinction coefficient  =  2,100 by the 
formula:
The analyses were performed in triplicate, and pigments 
were normalized relative to the dry weight of the yeast. 
Carotenoids were separated by RP-HPLC using a reverse 
phase C18 column with acetonitrile:methanol:isopropyl 
(85:10:5 v/v) as mobile phase, with a 1  mL/min flux, 
under isocratic conditions. The elusion spectra were 
recuperated using a diode array detector.
Quantitative real‑time PCR
For the gene expression analysis, 2  mL of each culture 
sample were centrifuged at 4°C for 5 min and the pellet 
was kept in a liquid nitrogen bath for freezing and then 
stored at −80°C for the next RNA extraction step. RNA 
isolation was performed using TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA) following the manufacturer’s 
instructions, and stored at −80°C to prevent nucleic acid 
degradation. Isolated RNA was treated with DNaseI, to 
remove residual genomic DNA. The purity and integrity 
of RNA was evaluated by electrophoresis in an agarose 
gel and measuring the A260/A280 ratio and concentration 
Total carotenoid
(
µg/g of yeasts
)
=
(ml of petrol)(A450)(100)
(21)
(
yeast dry weight
)
in a Nanodrop spectrophotometer. Total RNA (2  μg) 
was reverse transcribed with a Maxima First Strand 
cDNA Synthesis Kit for RT-qPCR (Thermo Scientific) 
following the manufacturer’s instruction. The qPCR was 
realized in a StepOne plus Real-Time PCR instrument 
(Applied Biosystems, Carlsbad, CA, USA) using the rea-
gent Fast SYBR Green Master Mix (Applied Biosystems) 
and specific primers for each gene (Additional file 2). For 
each strain, three clones were analyzed and three tech-
nical replicates were done for each qPCR measurement. 
The cycle threshold (CT) values and efficiency values 
obtained were used for further analysis and calculation 
of relative expression levels. Each sample was normalized 
using TEF1, as internal control, and then the results from 
samples JLS03–JLS07 were compared to those in JLS02, 
as a calibrator sample.
Batch fermentation
Batch cultures were conducted in a 2 L working volume 
of a 2.5  L aerated stirred bioreactor, BioFlo IIc (New 
Brunswick Scientific). The medium contained 5  g/L of 
(NH4)2SO4, 1.7  g/L yeast nitrogen base without amino 
acids and ammonium sulfate, 0.77  g/L CSM-Ura and 
20  g/L glucose. After autoclaving (121°C, 20  min), a fil-
tered-sterilized vitamin solution, prepared according to 
van Hoek et al. [37], was added to the medium as well as 
10% (v/v) dodecane for in situ recovery of β-ionone. The 
fermenter was inoculated with an adequate aliquot of a 
pre-culture grown in shake flasks prepared in the same 
medium as described above to give an initial OD600 of 0.1.
During the cultivation, the broth was kept at 20°C, 
600  rpm agitation and an air flow rate of 1.0  L/min. A 
20% (w/v) solution of NaOH was employed to maintain 
the culture pH automatically at 5.0. Samples were col-
lected every 4  h for kinetics parameters and metabolite 
measurements. Glucose and ethanol were measured by 
HPLC as described Sanchez et al. [38]. The organic layer 
was collected at the same times in the fermentation for 
β-ionone quantification by GC-FID.
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